cancer

Illumina Buys Cancer Test Startup Grail for $8B
M&A

Illumina Buys Cancer Test Startup Grail for $8B

The deal will move Illumina “deeper into the application of its gene-sequencing technology to the diagnosis and treatment of patients."
By Matthew Heller | September 21, 2020
Read More
J&J Buys Auris for $3B in Surgical Robotics Play
Technology

J&J Buys Auris for $3B in Surgical Robotics Play

The deal is J&J's biggest move into surgical robotics, which "has been a gap for its medical device business."
By Matthew Heller | February 13, 2019
Read More
Monsanto Cancer Verdict Rattles Bayer Shares
Risk & Compliance

Monsanto Cancer Verdict Rattles Bayer Shares

Analysts warn Bayer could face a "litigious headache" after the $289 million jury award in a product liability case over Monsanto's Roundup pesticide.
By Matthew Heller | August 14, 2018
Read More